Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001225208-18-005280
Filing Date
2018-03-05
Accepted
2018-03-05 16:39:49
Documents
1
Period of Report
2018-03-01

Document Format Files

Seq Description Document Type Size
1 doc3.html 3  
1 doc3.xml 3 1960
  Complete submission text file 0001225208-18-005280.txt   3418
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3M CENTER ST PAUL MN 551441000
Business Address
THULIN INGE G (Reporting) CIK: 0001263739 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-06571 | Film No.: 18666619